Guoke Medical DOA Rapid Urine Test Cup: What Buyers Can Verify

DOA Rapid Urine Test Device Cup (Colloidal Gold )

The device is described as a lateral flow chromatographic immunoassay for qualitative detection of multiple drugs in urine, including MEF, KET, MDMA, BAR, BUP, MTD, TCA, TRA, K2, ETG, OXY, FYL, MQL, LSD, and SOMA.

Product code GKPD044 and pack formats of 1/10/20/25/40/50T per box are stated. The biomarker field lists urine. The word “etc.” leaves the exact panel composition to confirmation rather than assumption.

Procurement depends on matching the required drug panel, cut-off concentrations, and reporting format to the intended workflow. None are supplied in the listing, so they should be clarified before purchase.

Because the product is intended for professional diagnostic or laboratory use, buyers should request instructions for use, kit inserts, expiration dates, storage conditions, and available regulatory or quality documents.

Minimum order quantity, lead time, shipping, and configuration should also be confirmed. Pack sizes range from single tests to 50 tests per box, so order planning needs the exact format.

The source does not provide sensitivity, specificity, or cut-off data. Operators should therefore treat validation, staff training, and lot-to-lot consistency checks as buyer-side responsibilities.

A multi-analyte urine cup can simplify collection and screening steps, but its value depends on panel fit, documentation, and supply continuity. Those are the points to verify before treating a catalogue entry as procurement-ready.

Why it matters:
Buyers should confirm the exact panel, cut-offs, and documents before ordering; the listing alone does not establish clinical or regulatory suitability.

View Product →